Cancer stem cells (CSCs) constitute a small but highly plastic sub-fraction of osteosarcoma that drives tumour heterogeneity, relapse, and metastatic spread; they are typically enriched in side-population or ALDH-bright fractions and display elevated ABC-transporter activity together with surface markers such as CD133 and CD44 [39]. Here, PROM1 is linked to osteosarcoma.